Canada has enough doses to vaccinate all eligible Canadians, says Trudeau

Canada has enough COVID-19 vaccine doses to fully vaccinate everyone eligible in the country, Prime Minister Justin Trudeau announced at a Moncton, N.B., vaccine clinic Tuesday morning.
The latest shipment of five million doses this week will bring the total number procured to over 66 million. That means there will be enough for the 33.2 million Canadians who are aged 12 and over.

“The best way to end this pandemic is for everyone to get their shots as soon as they can,” said Trudeau. “Today’s milestone is a clear sign that we are getting closer to this goal. I urge Canadians to book their vaccine today, to protect themselves, their loved ones, and their communities.”

Procurement Minister Anita Anand added that team effort between the government, vaccine suppliers and public servants was responsible for achieving this milestone “two months ahead of our original projection”.

Health Minister Patty Hajdu urged everyone who is eligible to get vaccinated to mitigate the possibility of a health and economic crisis brought on by a fourth wave expected in the fall.

“If you haven’t been vaccinated yet, please make a plan to do so. Our families, communities and small businesses are relying on us to take care of each other and stop the spread,” Hajdu said. “We are regaining so many of the things we enjoy: seeing our families, visiting with friends and going out to eat. Let’s keep going together. Be safe, be sure. Get vaccinated today.”

According to the government’s most recent data released last Friday, 57.45 per cent of Canadians 12 and over are fully vaccinated, and 79.66 per cent have received at least one dose.

Federal officials also said that Canada has secured COVID-19 vaccines from Pfizer for 2022 and 2023, with options to extend into 2024. In addition to providing booster vaccine doses, the agreement provides flexibility to procure new adaptations of the Pfizer-BioNTech COVID-19 vaccine, such as those to protect against mutations or variants of concern and vaccines developed for younger populations.



Please enter your comment!
Please enter your name here